-
Spiroplasma Entry into Drosophila S2 Cells
2026-08-20
Wei et al. established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris both damages host cells and actively enters them through clathrin-mediated endocytosis and macropinocytosis. The study combines pharmacological inhibition, cytoskeletal perturbation, microscopy, and intracellular bacterial quantification to define an entry process relevant to invertebrate infection biology.
-
S63845: MCL1 Dependency in Translational Apoptosis
2026-08-19
S63845 provides a selective way to interrogate MCL1 dependency, mitochondrial apoptosis, and residual disease biology. This thought-leadership perspective connects mechanistic evidence from chemotherapy-induced senescence with practical assay design and translational strategy in hematological cancer research.
-
Pravastatin sodium: Assay Workflows and Optimization
2026-08-19
Build reproducible cholesterol, macrophage, and hepatocyte assays with Pravastatin sodium, an HMG-CoA reductase inhibitor suited to concentration-response and transporter-aware study designs. The workflow combines pathway-specific readouts with viability controls to distinguish cholesterol biosynthesis inhibition from nonspecific cellular stress.
-
Dual Metabolic Reprogramming in TNBC Ferroptosis
2026-08-18
The reference study identifies a previously overlooked trade-off in brequinar-mediated ferroptosis: DHODH inhibition can sensitize tumor cells to oxidative death while increasing lipid-droplet accumulation that reinforces resistance. Its AB@HA-TA/Fe nanoplatform co-delivers brequinar and the DGAT1 inhibitor A922500, producing dual metabolic intervention and antitumor activity in 4T1 models in vitro and in vivo.
-
Self-Amplifying RNA for Dose-Sparing Influenza Vaccines
2026-08-18
This study directly compares nucleoside-modified mRNA, self-amplifying RNA, and circular RNA vaccines across seasonal influenza subtypes. Its central finding is that a low-dose trivalent self-amplifying RNA formulation overcame the weak influenza B response observed with conventional mRNA and produced durable protection in mice.
-
From ROS Signal to Mechanism: DCFH-DA in PCOS
2026-08-17
A translational framework for using 2,7-Dichlorodihydrofluorescein diacetate and DCFH-DA to connect oxidative-stress measurements with granulosa-cell biology, pathway validation, and therapeutic decision-making in PCOS research.
-
FPH1 (BRD-6125) Hepatocyte Workflow Guide
2026-08-17
FPH1 (BRD-6125) supports a practical route to expanding functional human hepatocytes while tracking proliferation and liver-specific performance in parallel. This guide connects primary human hepatocyte culture and iPS-derived hepatocyte workflows with quantitative readouts, compound-handling controls, and a carefully bounded perspective on optogenetic gene-regulation research.
-
Omeprazole A2845: H+,K+-ATPase Protocol
2026-08-16
Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for gastric acid secretion research, assay development, and antiulcer activity study workflows. It is intended for controlled scientific experiments only, not for diagnosis, treatment, or direct medical use, and its aqueous handling is limited by poor water solubility.
-
Hyaluronic Acid Sodium Salt for ECM and siRNA
2026-08-15
Hyaluronic acid sodium salt supports reproducible extracellular matrix models, migration assays, and nanoparticle-coating workflows when molecular weight, dispersion, and controls are managed carefully. Its high-molecular-weight matrix behavior also provides a practical bridge to HA-coated siRNA studies targeting inflammatory tissue injury.
-
Prion-Based Self-Assembly Tunes Mutagenesis
2026-08-14
A 2026 Cell study shows that prion-like self-assembly of DNA repair and recombination proteins can reversibly tune mutagenesis in yeast, reshaping adaptation under strong selection. Cross-species evidence in Candida albicans links prion inheritance control to rapid fluconazole resistance, identifying protein-state inheritance as a potential regulator of genome evolution.
-
KX2-391 Inhibits HBV Transcription: Study Analysis
2026-08-14
A recombinant HBV–NanoLuc screening platform identified KX2-391 as a dose-dependent inhibitor of HBV infection and transcription. The study links this antiviral activity to tubulin polymerization inhibition rather than Src kinase suppression, while defining the HBV precore promoter and enhancer II as important points of action.
-
LMO2–LDB1 Signaling in Acute Myeloid Leukemia
2026-08-13
This study identifies a functional LMO2/LDB1 protein complex that supports acute myeloid leukemia cell proliferation and survival. By combining protein interaction analysis, genetic perturbation, transcriptomics, chromatin profiling, and in vivo experiments, the authors position LDB1 as an important AML dependency and provide a mechanistic basis for investigating the complex therapeutically.
-
InstaBlue Protein Stain Solution: Practical Guide
2026-08-13
InstaBlue Protein Stain Solution is a ready-to-use Coomassie Brilliant Blue protein stain for rapid visualization of protein bands in polyacrylamide gels. It is suited to routine protein electrophoresis analysis and workflows that may proceed to mass spectrometry, but staining intensity should not be treated as a substitute for a validated protein quantification assay.
-
α-Amanitin for RNA Polymerase II Assays
2026-08-12
α-Amanitin provides a practical transcriptional blockade for separating RNA polymerase II activity from downstream translation, RNA stability, and developmental phenotypes. This guide translates its mechanism into cell, biochemical, and preimplantation embryo workflows, with optimization strategies informed by recent tRNA-enabled mRNA translation research.
-
L-Phenylephrine α1A Signaling Workflows
2026-08-12
L-Phenylephrine provides a practical α1A-focused perturbation tool for connecting adrenergic receptor biology with cardiomyocyte, neural progenitor, and vascular assays. This workflow combines receptor-selective controls, sex-aware cardiovascular design, and troubleshooting guidance to improve interpretability from cultured cells to conscious-animal studies.